Levomepromazine
Material: | 1 ml serum |
Indication | Therapeutic drug monitoring |
Therapeutic range | 30 µg/l – 160 µg/l |
Please note | Levomepromazine is a “typical” low potent neuroleptic (phenothiazine derivate, dopamine antagonist). As all substances of this group, it has sedating and antipsychotic effect. It has all characteristic dosage-dependent side effects of this substance class (especially extrapyramidal symptoms such as dyskinesia, Parkinsonism, akathisia etc.) |
Accredited | ja |
More Results for the letter L
- Lipometabolism diagnostics (LIPID)
- fat metabolism diagnostics
- Lipoprotein (a) = Lp (a) (LPA)
- Listeriosis (KLIST, LISMON)
- Listeria monocytogenes
- Lithium (LI)
- LKM autoantibodies (LKM)
- autoantibodies to liver and kidney microsomes
- LMA autoantibodies (LMA)
- Liver membrane antigen autoantibodies
- Lorazepam (LORA)
- Lormetazepam (LORM)
- LSD (LSDU)
- Lysergic acid diethylamide
- Lupus coagulant activity (LUPAK)
- Lymphocyte differentiation (LYMPD, LYMPDG, TREG, TAKT)
- Immune status
- Lysozyme (LYSOZ)